Fundraising Fox

Boson Ventures

Venture capital

Melbourne · Pre-Seed–Series A · 9 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Boson Ventures argues that Australia produces world-class, Nobel-caliber science but has historically failed to commercialise it domestically, with talent and companies leaving the country. It sees the 2020-2027 period as an entry window, supported by the A$15B National Reconstruction Fund and fewer than 12 active local deep-tech investors, before valuations normalise. The firm backs pre-seed to Series A deep-tech founders across bio and medical, advanced manufacturing, AI and robotics, and climate and energy. Its stated edge is deep technical due diligence capability that few Australian funds possess, plus a direct commercialisation corridor into Greater China. Funds are ESVCLP-eligible, offering investors tax offsets.

Source: firm website, verified Jul 30, 2026.

Stage
Pre-Seed–Series A
HQ
Melbourne, AU
Leads rounds
Leads
Instruments
Equity
Tracked investments
10

Team · 9 people

from the firm's website
Alan Cui· Managing Partner

Physics-trained former founder of a deep tech startup with a successful exit, and a key executive who scaled an Australian business from $17M to $100M EBITDA. Previously a management consultant at top-tier firms in China and Australia.

Dr Xian Bu· Partner

Inventor of one of only two FDA-approved small-molecule drugs originating from Australia. Founder & CEO of SYNthesis Med Chem, former Chief Business Officer and EVP at Viva Biotech, and co-inventor of 16+ drug patents.

Helena Liu· Partner

Former corporate finance and M&A specialist at AstraZeneca and Philips, with a decade in asset management as Managing Director of Hong Kong's largest multi-family office, and a healthcare angel investor.

Hover Chen· Partner

Experienced healthcare investor and early backer of several listed Chinese biotechs, who has managed cross-border venture capital and global hedge funds in healthcare and TMT.

Andrew Senduk· Advisor

Former founder with two successful exits and ex-managing director of Workmate, an operating partner at Workplace Accelerator and former VP at ING, as well as a global keynote speaker and angel investor.

Dr Dharmica Mistry· Advisor, Healthcare IC

Co-founder and former Chief Scientist of a listed company and Board Director of BioNSW, recognized for developing a national diagnostics development strategy.

Gilbert Michaca· Advisor, Adv. Manufacturing IC

Former CEO of an ASX-listed additive manufacturing firm and CEO of Grey Innovation, a Non-Executive Director in European biotech, and former SVP of biopharma in Europe who led US expansion.

Stu Philpot· Advisor

Co-founder of a climate tech company that reached A$12M revenue growth in under four years without external funding, and Head of Strategic Partnership at AGL New Energy.

Wei Qian· Advisor

Former partner and Managing Director of Accenture Strategy Greater China, and previously Vice President of Investment Banking at Morgan Stanley in Japan.

Investments · 10 tracked

founders shown can be your intro path
AI-NC

AI platform (Manufact) giving engineers instant cost estimates and optimal manufacturing methods from part designs.

Catalyser

All-in-one corporate social responsibility platform for APAC enterprises covering donations, gift matching and volunteering.

Clarity Pharmaceutical

Clinical-stage radiopharmaceutical company developing theranostic oncology products via its SAR Technology platform.

Fiable

AI-powered financial viability platform assessing risk across construction and infrastructure projects.

Hello Clever

AI-powered real-time payment and loyalty platform for Gen Z consumers, expanding across APAC.

Junshi Bio

Innovation-driven biopharmaceutical company with a diversified pipeline across oncology, autoimmune, metabolic, neurological and infectious diseases.

Kite Magnetics

Monash spinout making rare-earth-free nanocrystalline magnets for high-efficiency motors in electric aircraft and EVs.

Loop+

Digital health platform for people with disabilities; wound down in 2024.

Osara Health

Digital health platform helping cancer patients manage their treatment journey with symptom tracking and care-team connection.

Storipress

Modern publishing platform for independent media; wound down in 2024.

Frequently asked questions

What stage does Boson Ventures invest at?
Boson Ventures invests at the Pre-Seed, Seed, Series A stages.
What sectors does Boson Ventures focus on?
Boson Ventures focuses on Advanced Manufacturing, AI & Machine Learning, Biotech, Climate Tech, Deep Tech, Energy, Medical Devices, Robotics.
Where is Boson Ventures located?
Boson Ventures is headquartered in Melbourne, AU.
Does Boson Ventures lead rounds?
Yes, Boson Ventures leads investment rounds.

Similar investors

Featured in lists